Other languages NexgenRx Inc.

Equities

NXG

CA65337X1042

Market Closed - Toronto S.E. Other stock markets 12:41:09 01/05/2024 am IST			5-day change	1st Jan Change
0.22 ^CAD	-.--%		-.--%	-.--%

05/04	NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/04
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	30/12
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	21/12
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	24/11
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	16/23/16
NexgenRx's Q1 Profit Falls, Revenue Rises	19/23/19
NexgenRx Inc. Appoints Dave Bennett as New Director	19/23/19
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19
NexgenRx Swings to Loss in Q4	10/23/10
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	30/22/30
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	24/22/24
NexgenRx Announced Q2 2022 Financial Results	19/22/19
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	19/22/19
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	18/22/18
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022	20/22/20
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending	19/21/19
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	19/21/19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NexgenRx Inc.

Equities

NXG

CA65337X1042

Other languages

Filters